Small cap wrap: Purepoint Uranium, Ocean Power Technologies, Power Metallic, 1911 Gold…

Crocs, Inc. (NASDAQ:CROX) shares fell almost 10% on Thursday after the footwear company issued a weaker-than-expected third quarter outlook, as tariff pressures and continued weakness at its HEYDUDE brand weighed on sentiment, despite a second-quarter earnings and revenue beat.

The company forecast Q3 adjusted earnings per share of $3.20 to $3.30 on roughly flat revenue, below Wall Street expectations for adjusted EPS of around $3.53 to $3.55 and revenue of about $1 billion. Crocs attributed the outlook to ongoing tariff impacts and product mix pressures.

Ocean Power Technologies Inc (NYSE-A:OPTT) has announced that it has delivered a WAM-V unmanned surface vehicle to Stevens Institute of Technology, completing an order that the company first announced in June.

The company said the vehicle was delivered five weeks after the order was placed and will be used to support marine research and development initiatives at Stevens Institute while expanding Ocean Power Technologies' presence in the academic research market.

M2i Global Inc (OTC:MTWO) announced that it has entered into a non-binding strategic collaboration with Evrensel Impact Group (EIG) to explore opportunities for identifying, evaluating and potentially developing critical minerals projects across Africa.

The companies said the collaboration is intended to combine EIG's network of government relationships, strategic partnerships and commercial engagements across the continent with M2i Global's critical minerals strategy. The arrangement establishes a framework for identifying opportunities that align with M2i's strategic priorities and evaluating potential future projects.

Power Metallic Mines Inc (TSX-V:PNPN, FRA:IVV1, OTCQB:PNPNF) announced that the release of its 2026 mineral resource estimate for the combined Nisk and Lion discoveries at its polymetallic Nisk project in Quebec has been delayed until the end of August due to scheduling constraints at the consulting engineering firm preparing the report.

The company said it learned late last week that the engineering firm, which already has the information required from Power Metallic, has experienced delays in staff availability because of concurrent workloads across multiple projects.

374Water Inc (NASDAQ:SCWO, FRA:8LL) has highlighted the role it believes advanced wastewater treatment technologies can play in protecting public health as US officials investigate one of the largest foodborne illness outbreaks in recent history.

The company noted that while investigators continue to determine the source of the outbreak, the incident underscores the importance of water infrastructure in reducing the spread of harmful contaminants through communities, food systems, and water supplies.

Purepoint Uranium Group Inc (TSX-V:PTU, OTCQX:PTUUF, FRA:P5X0) said the first phase of its 2026 summer drilling program at the Dorado project delivered a broad radioactive intercept in the final hole completed before a scheduled mid-program break.

Hole NV26-11 intersected 5.6 metres of continuous radioactivity averaging 11,730 counts per second (cps) from the downhole probe, including a peak reading of 53,300 cps, at the Nova Discovery.

Phunware Inc (NASDAQ:PHUN, FRA:2RJA) has appointed Nick Farrell as senior vice president of sales and added Aaron Holloway and Michael Crooks as advisors, the mobile enterprise guest intelligence platform company said, building on momentum from its showing at HITEC North America 2026 in San Antonio.

The appointments follow strong engagement at the hospitality technology conference, where Phunware demonstrated its Guest Intelligence Platform, including its AI Concierge and AI Itinerary Builder.

1911 Gold Corp (TSX-V:AUMB, OTCQB:AUMBF, FRA:2KY) said assay results from its latest exploration program at the True North Gold Project in Manitoba confirmed high-grade gold mineralization over a 720-metre strike length and to depths of nearly 975 metres.

The results come from 30 drill holes totaling 8,656 metres testing the San Antonio Southeast (SAM SE) and Shore targets.

Trillion Energy International Inc. (CSE:TCF, OTCQB:TRLEF, FRA:Z620) will change its name to Dune Oil Corp, the company said, as it shifts its strategic focus toward oil development and exploration.

The name change takes effect August 4, when the company's shares will begin trading under the new ticker "DUNE" on the Canadian Securities Exchange.

Sovereign Metals Ltd (ASX:SVM, OTCQX:SVMLF, AIM:SVML, FRA:SVM), in its quarterly activities report, told investors it aims to position the Kasiya project as a non-Chinese source of titanium feedstock, graphite and potentially heavy rare earths for US and allied supply chains, backed by A$25.1 million of cash at the end of June.

The Malawi-based project’s definitive feasibility study produced a pre-tax net present value of US$2.2 billion and a 23% internal rate of return. Capital expenditure to first production is estimated at US$727 million, with steady-state annual EBITDA forecast at US$476 million and pre-tax free cash flow at US$452 million.

Horizon Gold Ltd (ASX:HRN, OTC:HZGLF, FRA:HO0) strengthened the development case for its 100%-owned Gum Creek Gold Project during the June quarter, completing a definitive feasibility study (DFS) that outlined a potential 10-year operation producing 880,000 ounces of gold.

The study confirmed a pathway to first production in the second half of 2028, with average output targeted at 98,000 ounces per annum during the first five years and 88,000 ounces annually across the full mine life.

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) is positioned to benefit from a new five-year, US$66.9 billion US Government strategy aimed at strengthening national defences against pandemics, antimicrobial resistance and other major biological threats.

The strategy identifies broad-spectrum antimicrobials as its second-largest single-threat funding priority, with an assessed US$4.46 billion required to support the development of new treatments for drug-resistant infections and priority pathogens.

American Rare Earths Ltd (ASX:ARR, OTCQX:ARRNF) has reaffirmed its commitment to securing a NASDAQ listing as it positions the Halleck Creek Rare Earths Project to benefit from growing US demand for domestically sourced critical minerals.

The company is evaluating several potential routes to the US exchange, including a direct compliance listing, a US initial public offering and alternative transaction structures available to developers with American critical minerals assets.

Titan Minerals Ltd (ASX:TTM, OTC:TTTNF) built strong momentum at its flagship Dynasty Gold Project during the June 2026 quarter, restarting resource drilling, identifying substantial extensions to mineralisation and advancing a scoping study scheduled for delivery in the fourth quarter.

Three diamond rigs are now operating across Dynasty in southern Ecuador as part of a 10,000-metre exploration and resource extension campaign designed to expand the project’s existing mineral resource of 65.55 million tonnes at 1.85 g/t gold and 12.38 g/t silver for 3.9 million ounces of gold and 26.1 million ounces of silver.

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has expanded the European commercial footprint of its FebriDx rapid diagnostic test after signing an exclusive distribution agreement with Romanian healthcare supplier Alpha Medical.

Under the agreement, Alpha Medical will manage sales, distribution and inventory for FebriDx throughout Romania, giving Lumos access to the distributor’s established customer base across primary care, urgent care and hospital settings.

Actinogen Medical Ltd (ASX:ACW, OTC:ATGGF) has maintained momentum across its clinical, regulatory and commercial programs during the June quarter, with its pivotal XanaMIA Alzheimer’s disease trial on schedule to deliver topline results in November 2026.

The fully enrolled Phase 2b/3 trial continued treatment and follow-up activities across participating sites, while an independent Data Monitoring Committee completed its third review of safety data from all 247 participants and recommended the study continue without amendment.